| Patent application number | Description | Published |
|---|
| 20100240537 | Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives - The invention relates to 6-(alkylbenzylamino)purine derivatives of the general formula I for use as cytokinin receptor antagonists, wherein R1 is selected from the group comprising hydroxyl, amino, nitro, thio and alkyl group, and R2 denotes one to four alkyl groups. The invention also relates to preparations containing these derivatives. | 09-23-2010 |
| 20110287111 | SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS - The invention relates to new substituted 6-(2-aminobenzylamino)purines, represented by the general formula I, which can be used in CDK inhibition, in particular, in the treatment of viral infections and diseases involving cell proliferation. The invention further includes pharmaceutical preparations containing substituted 6-(2-aminobenzylamino)purines. | 11-24-2011 |
| 20120070512 | Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives - The invention relates to substituted 6-(2-hydroxybenzylamino)purines of general formula I, to their activity as cyclin-dependent kinases 2, 5, 7 and 9 inhibitors and to their use as medicaments, particularly in the treatment of disorders involving cell proliferation or inflammation. The invention further includes pharmaceutical compositions containing the substituted 6-(2-hydroxybenzylamino)purines. | 03-22-2012 |
| Patent application number | Description | Published |
|---|
| 20090170879 | 6,9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions - Certain 6,9-disubstituted purine derivatives and their pharmaceutically acceptable salts are provided. These 6,9-disubstituted purine derivatives and their pharmaceutically acceptable salts are useful in compositions for treating mammalian cells, and especially human skin cells, in order to ameliorate the adverse effects of aging, treat skin disease states, treat immunological responses resulting from or associated with inflammation, and the like. | 07-02-2009 |
| 20100190806 | SUBSTITUTED 6-ANILINOPURINE DERIVATIVES AS INHIBITORS OF CYTOKININ OXIDASE/DEHYDROGENASE AND PREPARATIONS CONTAINING THESE DERIVATIVES - The invention relates to substituted 6-anilinopurine derivatives of the general formula I, wherein R denotes one to five substituents independently selected from the group consisting of hydrogen, halogen, hydroxyl, amino, alkyloxy and alkyl group, and R2 denotes amino, halogen, nitro, thio, alkylthio or alkyl group for use as inhibitors of cytokinin oxidase/dehydrogenase. The invention also relates to the compositions containing these derivatives. | 07-29-2010 |
| 20100234401 | 6,9-Disubstituted Purine Derivatives and Their Use For Treating Skin - The present invention provides methods and compositions for countering the adverse effects of aging on mammalian cells in vitro and in vivo, especially human skin cells and human skin, and treatment of hyperproliferative and related skin diseases in mammals by administering compositions containing 6,9-disubstituted purine derivatives. | 09-16-2010 |
| 20110224238 | 6, 9-Disubstituted Purine Derivatives and Their Use for Treating Skin - The present invention provides methods and compositions for countering the adverse effects of aging on mammalian cells in vitro and in vivo, especially human skin cells and human skin, and treatment of hyperproliferative and related skin diseases in mammals by administering compositions containing 6,9-disubstituted purine derivatives. | 09-15-2011 |
| 20110230503 | 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions - Certain 6,9-disubstituted purine derivatives and their pharmaceutically acceptable salts are provided. These 6,9-disubstituted purine derivatives and their pharmaceutically acceptable salts are useful in compositions for treating mammalian cells, and especially human skin cells, in order to ameliorate the adverse effects of aging, treat skin disease states, treat immunological responses resulting from or associated with inflammation, and the like. | 09-22-2011 |
| Patent application number | Description | Published |
|---|
| 20100182666 | SHEETING WITH COMPOSITE IMAGE THAT FLOATS - Techniques are described for forming microlens sheeting having composite images that appear to float with respect to the plane of the sheeting. As one example, a method comprises forming one or more images within a sheeting having a surface of microlenses, wherein at least one of the images is a partially complete image, and wherein each of the images is associated with a different one of the microlenses, wherein the microlenses have refractive surfaces that transmit light to positions within the sheeting to produce a plurality of composite images from the images formed within the sheeting so that each of the composite images appears to float with respect to the plane of the sheeting, and wherein forming the one or more images comprises forming the one or more images such that each of the composite images is associated with a different viewing angle range. | 07-22-2010 |
| 20110236651 | METHODS OF FORMING SHEETING WITH A COMPOSITE IMAGE THAT FLOATS AND SHEETING WITH A COMPOSITE IMAGE THAT FLOATS - Microlens sheetings with composite images are disclosed, in which the composite image floats above or below the sheeting, or both. The composite image may be two-dimensional or three-dimensional. Methods for providing such an imaged sheeting are also disclosed. | 09-29-2011 |
| 20120019607 | SHEETING WITH COMPOSITE IMAGE THAT FLOATS - Translucent, transparent, or semi-translucent microlens sheetings with composite images are disclosed, in which a composite image floats above or below the sheeting, or both. The composite image may be two-dimensional or three-dimensional. The sheeting may have at least one layer of material having a surface of microlenses that form one or more images at positions internal to the layer of material, at least one of the images being a partially complete image. Additional layers, such as retroreflective, translucent, transparent, or optical structure layers may also be incorporated into the sheeting. | 01-26-2012 |
